These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4425844)

  • 61. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
    Ogarek I; Szczęsny-Choruz E; Wierzchowska-Słowiaczek E; Kwinta-Rybicka J; Stec Z; Moczulska A; Wilkosz K; Drożdż D
    Pol Merkur Lekarski; 2018 Apr; 44(262):192-195. PubMed ID: 29775447
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood.
    Barratt TM; Cameron JS; Chantler C; Ogg CS; Soothill JF
    Arch Dis Child; 1973 Apr; 48(4):286-90. PubMed ID: 4574639
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Optimization of the treatment of idiopathic nephrotic syndrome in children].
    Porcellini MG; Amore A; Gianoglio B; Peruzzi L; Coppo R
    Minerva Urol Nefrol; 1994 Dec; 46(4):233-7. PubMed ID: 7701411
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Late nonresponsiveness to steroids in children with the nephrotic syndrome.
    Trainin EB; Boichis H; Spitzer A; Edelmann CM; Greifer I
    J Pediatr; 1975 Oct; 87(4):519-23. PubMed ID: 1159578
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Long-term follow-up of the effectiveness of cyclophosphamide in corticodependent and corticoresistant infantile nephrosis. 282 cases treated in an 8-year period].
    Forese S; Tamborino G; Genova R
    Minerva Pediatr; 1977 Mar; 29(8):547-50. PubMed ID: 865435
    [No Abstract]   [Full Text] [Related]  

  • 67. Treatment of nephrotic syndrome with levamisole.
    Tanphaichitr P; Tanphaichitr D; Sureeratanan J; Chatasingh S
    J Pediatr; 1980 Mar; 96(3 Pt 1):490-3. PubMed ID: 6965715
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q; Li H; Xie X; Qu F; Li X; Chen J
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA; Esezobor CI; Lesi FE
    Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Combined treatment with corticosteroids and cyclophosphamide in the nephrotic syndrome in children].
    Chaimowitz S; Surasky M; Levi J; Benderly A
    Harefuah; 1972 Sep; 83(6):234-6. PubMed ID: 4650395
    [No Abstract]   [Full Text] [Related]  

  • 71. Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.
    White RH; Cameron JS; Trounce JR
    Br Med J; 1966 Oct; 2(5518):853-60. PubMed ID: 5917404
    [No Abstract]   [Full Text] [Related]  

  • 72. Cyclophosphamide for nephrotic syndrome in children.
    Br Med J; 1969 Mar; 1(5645):660-1. PubMed ID: 5774311
    [No Abstract]   [Full Text] [Related]  

  • 73. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients].
    Caletti MG; Gallo G; Zumino D; Díaz MA; Vitacco M
    Bol Med Hosp Infant Mex; 1981; 38(3):457-72. PubMed ID: 7271977
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term outcome of primary nephrotic syndrome.
    Koskimies O; Vilska J; Rapola J; Hallman N
    Arch Dis Child; 1982 Jul; 57(7):544-8. PubMed ID: 7103547
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Long-term effects of cyclophosphamide therapy in treatment of the "primary" nephrotic syndrome of childhood].
    Lama G
    Pediatria (Napoli); 1976 Jun; 84(2):320-30. PubMed ID: 798171
    [No Abstract]   [Full Text] [Related]  

  • 77. Treatment of IgA nephropathy of adults presented by nephrotic syndrome.
    Rasić S; Uncanin S; Aganović K; Rasić I; Dzemidzić J; Muslimović A
    Bosn J Basic Med Sci; 2008 Aug; 8(3):230-3. PubMed ID: 18816254
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Treatment of corticoid-resistant nephrotic syndrome: a still unresolved problem].
    Damiani B; Giani M; Consalvo G; Carcano A; Ghio L; Edefonti A
    Pediatr Med Chir; 1995; 17(1):9-15. PubMed ID: 7739938
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cyclophosphamide in the treatment of adult nephrotic syndrome.
    Gulati PD; Rizvi SN; Ajmani SK; Bhasin RC; Vaishnava H
    J Assoc Physicians India; 1973 Jan; 21(1):23-9. PubMed ID: 4792697
    [No Abstract]   [Full Text] [Related]  

  • 80. Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome.
    Rüth EM; Kemper MJ; Leumann EP; Laube GF; Neuhaus TJ
    J Pediatr; 2005 Aug; 147(2):202-7. PubMed ID: 16126050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.